Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 35 of 35 entries
Sorted by: Best Match Show Resources per page
The inconsistency and instability of Parkinson's disease motor subtypes.

Parkinsonism & related disorders

von Coelln R, Gruber-Baldini AL, Reich SG, Armstrong MJ, Savitt JM, Shulman LM.
PMID: 34091412
Parkinsonism Relat Disord. 2021 Jul;88:13-18. doi: 10.1016/j.parkreldis.2021.05.016. Epub 2021 May 21.

INTRODUCTION: Tremor-dominant (TD), indeterminate/mixed (ID/M) and postural instability gait difficulty/akinetic-rigid (PIGD/AR) are commonly used subtypes to categorize Parkinson's disease (PD) patients based on their most prominent motor signs. Three different algorithms to determine these motor subtypes are used. Here,...

Cite
von Coelln R, Gruber-Baldini AL, Reich SG, et al. The inconsistency and instability of Parkinson's disease motor subtypes. Parkinsonism Relat Disord. 2021;88:13-18doi: 10.1016/j.parkreldis.2021.05.016.
von Coelln, R., Gruber-Baldini, A. L., Reich, S. G., Armstrong, M. J., Savitt, J. M., & Shulman, L. M. (2021). The inconsistency and instability of Parkinson's disease motor subtypes. Parkinsonism & related disorders, 8813-18. https://doi.org/10.1016/j.parkreldis.2021.05.016
von Coelln, R, et al. "The inconsistency and instability of Parkinson's disease motor subtypes." Parkinsonism & related disorders vol. 88 (2021): 13-18. doi: https://doi.org/10.1016/j.parkreldis.2021.05.016
von Coelln R, Gruber-Baldini AL, Reich SG, Armstrong MJ, Savitt JM, Shulman LM. The inconsistency and instability of Parkinson's disease motor subtypes. Parkinsonism Relat Disord. 2021 Jul;88:13-18. doi: 10.1016/j.parkreldis.2021.05.016. Epub 2021 May 21. PMID: 34091412.
Copy Download .nbib Format: NLM
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer.

Antibodies (Basel, Switzerland)

Peerschke EI, Stanchina E, Chang Q, Manova-Todorova K, Barlas A, Savitt AG, Geisbrecht BV, Ghebrehiwet B.
PMID: 33036212
Antibodies (Basel). 2020 Oct 06;9(4). doi: 10.3390/antib9040051.

gC1qR is highly expressed in breast cancer and plays a role in cancer cell proliferation. This study explored therapy with gC1qR monoclonal antibody 60.11, directed against the C1q binding domain of gC1qR, in a murine orthotopic xenotransplant model of...

Cite
Peerschke EI, Stanchina E, Chang Q, et al. Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies (Basel). 2020;9(4)doi: 10.3390/antib9040051.
Peerschke, E. I., Stanchina, E., Chang, Q., Manova-Todorova, K., Barlas, A., Savitt, A. G., Geisbrecht, B. V., & Ghebrehiwet, B. (2020). Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies (Basel, Switzerland), 9(4), . https://doi.org/10.3390/antib9040051
Peerschke, Ellinor I, et al. "Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer." Antibodies (Basel, Switzerland) vol. 9,4 (2020). doi: https://doi.org/10.3390/antib9040051
Peerschke EI, Stanchina E, Chang Q, Manova-Todorova K, Barlas A, Savitt AG, Geisbrecht BV, Ghebrehiwet B. Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies (Basel). 2020 Oct 06;9(4). doi: 10.3390/antib9040051. PMID: 33036212; PMCID: PMC7709104.
Copy Download .nbib Format: NLM
James E. Copeland, a country doctor in an age of medical change.

Virginia cavalcade

Savitt TL.
PMID: 11636162
Va Cavalcade. 1973;23:10-7.

No abstract available.

Cite
Savitt TL. James E. Copeland, a country doctor in an age of medical change. Va Cavalcade. 1973;23:10-7
Savitt, T. L. (1973). James E. Copeland, a country doctor in an age of medical change. Virginia cavalcade, 2310-7.
Savitt, T L. "James E. Copeland, a country doctor in an age of medical change." Virginia cavalcade vol. 23 (1973): 10-7.
Savitt TL. James E. Copeland, a country doctor in an age of medical change. Va Cavalcade. 1973;23:10-7. PMID: 11636162.
Copy Download .nbib Format: NLM
The many faces of celiac disease.

Gastroenterology & hepatology

Asamoah V, von Coelln R, Savitt J, Lee LA.
PMID: 22298993
Gastroenterol Hepatol (N Y). 2011 Aug;7(8):549-54.

No abstract available.

Cite
Asamoah V, von Coelln R, Savitt J, et al. The many faces of celiac disease. Gastroenterol Hepatol (N Y). 2011;7(8):549-54
Asamoah, V., von Coelln, R., Savitt, J., & Lee, L. A. (2011). The many faces of celiac disease. Gastroenterology & hepatology, 7(8), 549-54.
Asamoah, Vivian, et al. "The many faces of celiac disease." Gastroenterology & hepatology vol. 7,8 (2011): 549-54.
Asamoah V, von Coelln R, Savitt J, Lee LA. The many faces of celiac disease. Gastroenterol Hepatol (N Y). 2011 Aug;7(8):549-54. PMID: 22298993; PMCID: PMC3264941.
Copy Download .nbib Format: NLM
Impact of Rising Grades of Internal Rectal Intussusception on Fecal Continence and Symptoms of Constipation.

Diseases of the colon and rectum

Hawkins AT, Olariu AG, Savitt LR, Gingipally S, Wakamatsu MM, Pulliam S, Weinstein MM, Bordeianou L.
PMID: 26651113
Dis Colon Rectum. 2016 Jan;59(1):54-61. doi: 10.1097/DCR.0000000000000510.

BACKGROUND: A theory of rectal intussusception has been advanced that intrarectal intussusception, intra-anal intussusception, and external rectal prolapse are points on a continuum and are a cause of fecal incontinence and constipation.OBJECTIVE: This study evaluates the association among rectal...

Cite
Hawkins AT, Olariu AG, Savitt LR, et al. Impact of Rising Grades of Internal Rectal Intussusception on Fecal Continence and Symptoms of Constipation. Dis Colon Rectum. 2016;59(1):54-61doi: 10.1097/DCR.0000000000000510.
Hawkins, A. T., Olariu, A. G., Savitt, L. R., Gingipally, S., Wakamatsu, M. M., Pulliam, S., Weinstein, M. M., & Bordeianou, L. (2016). Impact of Rising Grades of Internal Rectal Intussusception on Fecal Continence and Symptoms of Constipation. Diseases of the colon and rectum, 59(1), 54-61. https://doi.org/10.1097/DCR.0000000000000510
Hawkins, Alexander T, et al. "Impact of Rising Grades of Internal Rectal Intussusception on Fecal Continence and Symptoms of Constipation." Diseases of the colon and rectum vol. 59,1 (2016): 54-61. doi: https://doi.org/10.1097/DCR.0000000000000510
Hawkins AT, Olariu AG, Savitt LR, Gingipally S, Wakamatsu MM, Pulliam S, Weinstein MM, Bordeianou L. Impact of Rising Grades of Internal Rectal Intussusception on Fecal Continence and Symptoms of Constipation. Dis Colon Rectum. 2016 Jan;59(1):54-61. doi: 10.1097/DCR.0000000000000510. PMID: 26651113.
Copy Download .nbib Format: NLM
Effect of diflubenzuron on the maturation and reproductive success of the copepod Eurytemora affinis.

Ecotoxicology (London, England)

Wright DA, Savitz JD, Dawson R, Magee J, Smucker RA.
PMID: 24193508
Ecotoxicology. 1996 Feb;5(1):47-58. doi: 10.1007/BF00116323.

: The insect growth regulator diflubenzuron (DFB) may have substantial effects on non-target organisms, especially crustaceans. By targeting the moulting process, DFB would be expected to elicit the most obvious effects on subadult crustaceans which moult frequently. Previous studies...

Cite
Wright DA, Savitz JD, Dawson R, et al. Effect of diflubenzuron on the maturation and reproductive success of the copepod Eurytemora affinis. Ecotoxicology. 1996;5(1):47-58doi: 10.1007/BF00116323.
Wright, D. A., Savitz, J. D., Dawson, R., Magee, J., & Smucker, R. A. (1996). Effect of diflubenzuron on the maturation and reproductive success of the copepod Eurytemora affinis. Ecotoxicology (London, England), 5(1), 47-58. https://doi.org/10.1007/BF00116323
Wright, D A, et al. "Effect of diflubenzuron on the maturation and reproductive success of the copepod Eurytemora affinis." Ecotoxicology (London, England) vol. 5,1 (1996): 47-58. doi: https://doi.org/10.1007/BF00116323
Wright DA, Savitz JD, Dawson R, Magee J, Smucker RA. Effect of diflubenzuron on the maturation and reproductive success of the copepod Eurytemora affinis. Ecotoxicology. 1996 Feb;5(1):47-58. doi: 10.1007/BF00116323. PMID: 24193508.
Copy Download .nbib Format: NLM
Treatment of Visual Disorders in Parkinson Disease.

Current treatment options in neurology

Savitt J, Mathews M.
PMID: 29936554
Curr Treat Options Neurol. 2018 Jun 23;20(8):30. doi: 10.1007/s11940-018-0519-0.

PURPOSE OF REVIEW: This article discusses visual disorders in both Parkinson disease (PD) and other Parkinsonian disorders. It is organized largely by the anatomical site of pathology and emphasizes practical treatments. Targeted treatment options include medications, surgery, occupational, and...

Cite
Savitt J, Mathews M. Treatment of Visual Disorders in Parkinson Disease. Curr Treat Options Neurol. 2018;20(8):30doi: 10.1007/s11940-018-0519-0.
Savitt, J., & Mathews, M. (2018). Treatment of Visual Disorders in Parkinson Disease. Current treatment options in neurology, 20(8), 30. https://doi.org/10.1007/s11940-018-0519-0
Savitt, Joseph, and Mathews, Michaela. "Treatment of Visual Disorders in Parkinson Disease." Current treatment options in neurology vol. 20,8 (2018): 30. doi: https://doi.org/10.1007/s11940-018-0519-0
Savitt J, Mathews M. Treatment of Visual Disorders in Parkinson Disease. Curr Treat Options Neurol. 2018 Jun 23;20(8):30. doi: 10.1007/s11940-018-0519-0. PMID: 29936554.
Copy Download .nbib Format: NLM
Lipid moieties of .

NPJ vaccines

Mara AB, Gavitt TD, Tulman ER, Geary SJ, Szczepanek SM.
PMID: 32284882
NPJ Vaccines. 2020 Apr 08;5(1):31. doi: 10.1038/s41541-020-0181-x. eCollection 2020.

Vaccine-enhanced disease (VED) occurs as a result of vaccination followed by infection with virulent

Cite
Mara AB, Gavitt TD, Tulman ER, et al. Lipid moieties of . NPJ Vaccines. 2020;5(1):31doi: 10.1038/s41541-020-0181-x.
Mara, A. B., Gavitt, T. D., Tulman, E. R., Geary, S. J., & Szczepanek, S. M. (2020). Lipid moieties of . NPJ vaccines, 5(1), 31. https://doi.org/10.1038/s41541-020-0181-x
Mara, Arlind B, et al. "Lipid moieties of ." NPJ vaccines vol. 5,1 (2020): 31. doi: https://doi.org/10.1038/s41541-020-0181-x
Mara AB, Gavitt TD, Tulman ER, Geary SJ, Szczepanek SM. Lipid moieties of . NPJ Vaccines. 2020 Apr 08;5(1):31. doi: 10.1038/s41541-020-0181-x. eCollection 2020. PMID: 32284882; PMCID: PMC7142147.
Copy Download .nbib Format: NLM
Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs.

General dentistry

Wirth NM, Henrichs LE, Savett D, Lien W, Crabtree M, Vandewalle KS, Kuranchie FA, Attiogbe F.
PMID: 34978992
Gen Dent. 2022 Jan-Feb;70(1):56-60.

The objective of this study was to evaluate the efficacy of various decontamination methods and subsequent sterilization on contaminated and inoculated diamond-coated burs. One hundred forty new diamond-coated burs and 120 extracted human molars were utilized in this study....

Cite
Wirth NM, Henrichs LE, Savett D, et al. Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs. Gen Dent. 2022;70(1):56-60
Wirth, N. M., Henrichs, L. E., Savett, D., Lien, W., Crabtree, M., Vandewalle, K. S., Kuranchie, F. A., & Attiogbe, F. (2022). Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs. General dentistry, 70(1), 56-60.
Wirth, Nicole M, et al. "Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs." General dentistry vol. 70,1 (2022): 56-60.
Wirth NM, Henrichs LE, Savett D, Lien W, Crabtree M, Vandewalle KS, Kuranchie FA, Attiogbe F. Efficacy of various decontamination methods and sterilization on contaminated and inoculated diamond-coated burs. Gen Dent. 2022 Jan-Feb;70(1):56-60. PMID: 34978992.
Copy Download .nbib Format: NLM
A GATA3 Targeting Nucleic Acid Nanocapsule for .

ACS nano

Gavitt TD, Hartmann AK, Sawant SS, Mara AB, Szczepanek SM, Rouge JL.
PMID: 34157834
ACS Nano. 2021 Jun 23; doi: 10.1021/acsnano.0c07781. Epub 2021 Jun 23.

Allergic asthma is one of the leading chronic lung diseases of both children and adults worldwide, resulting in significant morbidity and mortality in affected individuals. Many patients have severe asthma, which is refractory to treatment, illustrating the need for...

Cite
Gavitt TD, Hartmann AK, Sawant SS, et al. A GATA3 Targeting Nucleic Acid Nanocapsule for . ACS Nano. 2021;doi: 10.1021/acsnano.0c07781.
Gavitt, T. D., Hartmann, A. K., Sawant, S. S., Mara, A. B., Szczepanek, S. M., & Rouge, J. L. (2021). A GATA3 Targeting Nucleic Acid Nanocapsule for . ACS nano, . https://doi.org/10.1021/acsnano.0c07781
Gavitt, Tyler D, et al. "A GATA3 Targeting Nucleic Acid Nanocapsule for ." ACS nano vol. (2021). doi: https://doi.org/10.1021/acsnano.0c07781
Gavitt TD, Hartmann AK, Sawant SS, Mara AB, Szczepanek SM, Rouge JL. A GATA3 Targeting Nucleic Acid Nanocapsule for . ACS Nano. 2021 Jun 23; doi: 10.1021/acsnano.0c07781. Epub 2021 Jun 23. PMID: 34157834.
Copy Download .nbib Format: NLM
Women with chronic constipation have more bothersome urogenital symptoms.

Techniques in coloproctology

Ortega MV, Kim Y, Hung K, James K, Savitt L, Von Bargen E, Bordeianou LG, Weinstein MM.
PMID: 34820751
Tech Coloproctol. 2022 Jan;26(1):29-34. doi: 10.1007/s10151-021-02518-4. Epub 2021 Nov 24.

BACKGROUND: The aim of our study was to characterize urogenital symptoms in women with and without constipation, and by severity of constipation.METHODS: This was a retrospective cohort study conducted at a pelvic floor disorder center in a tertiary healthcare...

Cite
Ortega MV, Kim Y, Hung K, et al. Women with chronic constipation have more bothersome urogenital symptoms. Tech Coloproctol. 2021;26(1):29-34doi: 10.1007/s10151-021-02518-4.
Ortega, M. V., Kim, Y., Hung, K., James, K., Savitt, L., Von Bargen, E., Bordeianou, L. G., & Weinstein, M. M. (2022). Women with chronic constipation have more bothersome urogenital symptoms. Techniques in coloproctology, 26(1), 29-34. https://doi.org/10.1007/s10151-021-02518-4
Ortega, M V, et al. "Women with chronic constipation have more bothersome urogenital symptoms." Techniques in coloproctology vol. 26,1 (2022): 29-34. doi: https://doi.org/10.1007/s10151-021-02518-4
Ortega MV, Kim Y, Hung K, James K, Savitt L, Von Bargen E, Bordeianou LG, Weinstein MM. Women with chronic constipation have more bothersome urogenital symptoms. Tech Coloproctol. 2022 Jan;26(1):29-34. doi: 10.1007/s10151-021-02518-4. Epub 2021 Nov 24. PMID: 34820751.
Copy Download .nbib Format: NLM
Showing 25 to 35 of 35 entries